NHC — National HealthCare Corporation stock price, charts and financials

QT77National HealthCare Corporation

National HealthCare Corporation (AMEX: NHC) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
208.20
-14.56-6.54%
NHCQT77National HealthCare Corporation·AMEX
208.20-6.54%
TA
Loading chart...
Screen all →
Snapshot
Index-P/E28.30EPS (ttm)7.87Insider Own16.86%Shs Outstand15.62MPerf Week-1.47%
Market Cap3.48BForward P/E27.95EPS next Y7.97Insider Trans-0.60%Shs Float12.65MPerf Month1.98%
Enterprise Value3.21BPEG-EPS next Q-Inst Own-Short Float5.64%Perf Quarter27.39%
Income124.00MP/S2.28EPS this Y1.27%Inst Trans-Short Ratio5.45Perf Half Y55.66%
Sales1.52BP/B3.17EPS next Y-ROA8.11%Short Interest713.06KPerf YTD62.49%
Book/sh70.23P/C11.15EPS next 5Y-ROE11.68%52W High217.46 -4.26%Perf Year131.97%
Cash/sh19.97P/FCF20.96EPS past 3/5Y74.24% 23.04%ROIC-0.34%52W Low87.89 136.88%Perf 3Y281.77%
Dividend Est.2.68 (1.29%)EV/EBITDA14.98Sales past 3/5Y12.05% 9.02%Gross Margin37.21%Volatility2.52% 3.17%Perf 5Y197.57%
Dividend TTM2.59 (1.24%)EV/Sales2.10EPS Y/Y TTM20.52%Oper. Margin-0.44%ATR (14)6.87Perf 10Y237.67%
Dividend Ex-DateJun 30, 2026Quick Ratio17.27Sales Y/Y TTM17.49%Profit Margin8.11%RSI (14)56.27Recom-
Dividend Gr. 3/5Y3.83% 3.99%Current Ratio17.27EPS Q/Q20.13%SMA200.93%Beta0.64Target Price-
Payout31.72%Debt/Eq0.08Sales Q/Q1.60%SMA508.03%Rel Volume0.84Prev Close222.76
Employees15,278LT Debt/Eq0.04EarningsAug 06SMA20035.52%Avg Volume126.40KPrice208.20
IPO DateJan 02, 1987Option/ShortYes / YesEPS/Sales Surpr.-Net Debt/EBITDA-0.31Volume106,058Change-6.54%
Latest News
Company

National HealthCare Corporation (NHC) is a prominent provider in the healthcare sector, involved in the operation, management, and service provision for a wide array of elder care and health facilities. Its diverse portfolio includes skilled nursing facilities, assisted living communities, independent living residences, homecare and hospice agencies, and a specialized behavioral health hospital. Within its skilled nursing environments, NHC offers extensive therapeutic and medical care. Patients recovering from conditions such as strokes, heart attacks, orthopedic injuries, neurological ailments, or other illnesses and disabilities benefit from licensed physical, speech, respiratory, and occupational therapies. These facilities also provide essential services like nutritional guidance, social support, recreational activities, and daily necessities such as housekeeping and laundry, all complemented by physician-prescribed medical treatments. Distinctive medical specialty units further enhance care, featuring memory care for individuals with Alzheimer's and similar disorders, alongside sub-acute nursing units. NHC's assisted living centers are designed to offer personal support, helping residents with everyday tasks including dressing, bathing, meal preparation, and medication management. The company also addresses mental well-being through behavioral health services for both adults and geriatric patients, treating psychiatric, emotional, and addictive conditions. Beyond direct facility care, NHC delivers additional healthcare programs, incorporating skilled services like infusion, wound care, and advanced physical, occupational, and speech therapies. Its offerings extend to hospice care, the operation of pharmacies, and a suite of corporate services encompassing management, accounting, financial, and insurance solutions. Furthermore, NHC engages in leasing its properties to third-party operators. As of February 18, 2022, NHC's operational footprint was substantial, comprising 75 skilled nursing facilities with a capacity of 9,473 beds, 24 assisted living facilities, 5 independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. Founded in 1971, National HealthCare Corporation is headquartered in Murfreesboro, Tennessee.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,5251,5111,2981,1421,0741,011981996980
Cost of Goods Sold Incl. D&A957486811712686666609593583
Gross Profit5661,025487429388345371404398
Selling, General and Administrative Excl. Other34043424141404141
Research and Development
000000000
Other Operating Expense539881358330315253283314301
Operating Income-714386573251484956
Interest Expense464011135
Unusual Expense
Non-Operating Income (Expense)174255532-410064224
Net Income Before Taxes1631621368927150528875
Income Taxes37403423711102016
Consolidated Net Income1241201026722139426859
Net Income From Continuing Operations1261231026520139426859
Net Income1241201026722139426859
EPS (Recurring)7.987.766.624.361.469.032.744.473.87
EPS (Basic, Before Extraordinaries)7.987.766.624.361.469.032.744.473.87
EPS (Diluted)7.877.676.534.341.458.992.724.443.87
EBITDA2142141831316819296134121
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio26.4517.8716.4721.2941.037.5624.4219.4720.27
Price To Sales Ratio2.181.361.241.210.831.011.021.301.20
Gross Margin37.1167.8437.5237.5736.1334.1237.8240.5640.61
Operating Margin-0.469.466.634.992.985.044.894.925.71
Net Margin8.137.947.865.872.0513.754.286.836.02
Shares Outstanding161515151515151515
Market Capitalization3,3312,0561,6131,3868931,0199961,2961,177
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$251.48$207.11$162.74$118.37$74.00 Close Price0.00M0.48M0.95M1.43M1.90MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
HASSAN EMIL EDirectorJun 22 '26Sale200.005,9371,187,40065,595Jun 23
HASSAN EMIL EDirectorJun 16 '26Sale199.971,563312,56171,532Jun 18
ADAMS ROBERT GDirectorJun 08 '26Option Exercise69.194,000276,76017,579Jun 10
Piercey LisaDirectorJun 01 '26Buy184.26949174,859949Jun 02
FLATT BEN ANDERSON SRSenior VP & CIOMay 22 '26Option Exercise94.104,000376,40025,375May 27
LAROCHE RICHARD F JRDirectorMay 21 '26Sale195.147,5001,463,566205,760May 22
Shelly Timothy J.Sr.VP OperationsMay 19 '26Sale197.221,853365,4441,294May 20
Flatt Stephen FowlerCEOMay 14 '26Option Exercise93.526,000561,12071,505May 18
KIDD BRIAN FSVP, CFOMay 14 '26Option Exercise93.714,500421,71033,630May 18
Trail Sandra Y.DirectorMay 06 '26Option Exercise55.753,140175,05510,640May 08
LAROCHE RICHARD F JRDirectorMay 05 '26Option Exercise71.647,500537,300213,260May 06
HASSAN EMIL EDirectorApr 30 '26Option Exercise71.647,500537,30073,095May 01
Dodson Vicki LSr.VP Patient SrvcsApr 22 '26Option Exercise94.104,000376,40018,413Apr 24
FLATT BEN ANDERSON SRSenior VP & CIOApr 09 '26Option Exercise53.943,734201,41223,284Apr 13
Dodson Vicki LSr.VP Patient SrvcsMar 16 '26Option Exercise53.943,734201,41216,447Mar 18
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.